These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27436421)

  • 21. Novel Type V-A CRISPR Effectors Are Active Nucleases with Expanded Targeting Capabilities.
    Aliaga Goltsman DS; Alexander LM; Devoto AE; Albers JB; Liu J; Butterfield CN; Brown CT; Thomas BC
    CRISPR J; 2020 Dec; 3(6):454-461. PubMed ID: 33146573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration.
    Klompe SE; Vo PLH; Halpin-Healy TS; Sternberg SH
    Nature; 2019 Jul; 571(7764):219-225. PubMed ID: 31189177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR as a strong gene editing tool.
    Shen S; Loh TJ; Shen H; Zheng X; Shen H
    BMB Rep; 2017 Jan; 50(1):20-24. PubMed ID: 27616359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diverse Class 2 CRISPR-Cas Effector Proteins for Genome Engineering Applications.
    Pyzocha NK; Chen S
    ACS Chem Biol; 2018 Feb; 13(2):347-356. PubMed ID: 29121460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Based Gene Drives for Pest Control.
    McFarlane GR; Whitelaw CBA; Lillico SG
    Trends Biotechnol; 2018 Feb; 36(2):130-133. PubMed ID: 29221716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
    Berkhout B; Gao Z; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
    Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
    Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9 for plant genome editing: accomplishments, problems and prospects.
    Paul JW; Qi Y
    Plant Cell Rep; 2016 Jul; 35(7):1417-27. PubMed ID: 27114166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR/Cas9 Guide RNA Design Rules for Predicting Activity.
    Hiranniramol K; Chen Y; Wang X
    Methods Mol Biol; 2020; 2115():351-364. PubMed ID: 32006410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying Novel Enhancer Elements with CRISPR-Based Screens.
    Klein JC; Chen W; Gasperini M; Shendure J
    ACS Chem Biol; 2018 Feb; 13(2):326-332. PubMed ID: 29300083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.
    Perčulija V; Lin J; Zhang B; Ouyang S
    Adv Sci (Weinh); 2021 Jul; 8(13):2004685. PubMed ID: 34254038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Era of CRISPR/ Cas9 Mediated Plant Genome Editing.
    Khurshid H; Jan SA; Shinwari ZK; Jamal M; Shah SH
    Curr Issues Mol Biol; 2018; 26():47-54. PubMed ID: 28879855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type III CRISPR-Cas System: Introduction And Its Application for Genetic Manipulations.
    Liu T; Pan S; Li Y; Peng N; She Q
    Curr Issues Mol Biol; 2018; 26():1-14. PubMed ID: 28879852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resources for the design of CRISPR gene editing experiments.
    Graham DB; Root DE
    Genome Biol; 2015 Nov; 16():260. PubMed ID: 26612492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9 editing of the genome for cancer modeling.
    Guernet A; Grumolato L
    Methods; 2017 May; 121-122():130-137. PubMed ID: 28288827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusion guide RNAs for orthogonal gene manipulation with Cas9 and Cpf1.
    Kweon J; Jang AH; Kim DE; Yang JW; Yoon M; Rim Shin H; Kim JS; Kim Y
    Nat Commun; 2017 Nov; 8(1):1723. PubMed ID: 29167440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene editing in mouse zygotes using the CRISPR/Cas9 system.
    Wefers B; Bashir S; Rossius J; Wurst W; Kühn R
    Methods; 2017 May; 121-122():55-67. PubMed ID: 28263886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Disruption Using Chemically Modified CRISPR-Cpf1 RNA.
    McMahon MA; Rahdar M
    Methods Mol Biol; 2021; 2162():49-60. PubMed ID: 32926377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversification of the CRISPR Toolbox: Applications of CRISPR-Cas Systems Beyond Genome Editing.
    Balderston S; Clouse G; Ripoll JJ; Pratt GK; Gasiunas G; Bock JO; Bennett EP; Aran K
    CRISPR J; 2021 Jun; 4(3):400-415. PubMed ID: 34152221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.